top of page
01_hero_network_purple_1920x1080.png

Participating Trials

CLARITY-IgAN brings together major randomised clinical trials in IgA nephropathy (IgAN), contributed by the investigators and sponsors who led them. Participating trials span the key therapy classes in development for IgAN, and new trials are welcome to join as they are completed.

03_section_forestplot_light_1920x1080_edited.jpg

VISIONARY
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy

​

ORIGIN3

A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With IgA Nephropathy (IgAN)

​

TELIGAN
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Telitacicept in Patients With Primary IgA Nephropathy

RAINIER
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy

BEYOND
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of BION-1301 in Adults With IgA Nephropathy

PREVAIL
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Felzartamab in Adults With IgA Nephropathy

ALIGN
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function

APPLAUSE-IgAN
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase III Study to Evaluate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

​

ICAN
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With IgA Nephropathy

​

PROTECT

A Phase 3, Randomized, Multicenter, Double-Blind, Active-Controlled Study of the Efficacy and Safety of Sparsentan for the Treatment of IgA Nephropathy

01_hero_network_purple_1920x1080.png

CONTACT US

CLARITY-IgAN is academically initiated and sponsored by The George Institute for Global Health, University of New South Wales. You can reach out to us using the form below:

The George Institute for Global Health, University of New South Wales

Health Translation Hub, Level 8, 55 Botany St

Randwick NSW 2031

Australia

09_divider_wave_purple_1920x200.png

© 2026 by CLARITY-IgAN. All rights reserved.

bottom of page